Wilkes University

Fellowship in Pharmacovigilance

Nesbitt School of Pharmacy - Stark Learning Complex.

The Sanofi Pasteur / Wilkes University two-year Pharmaceutical Industry Fellowship Program is a comprehensive experience for Doctor of Pharmacy graduates to gain exposure in pharmacovigilance for vaccines.

At Sanofi Pasteur, the Vaccines Global Business Unit of Sanofi, we believe in a world where no one suffers or dies from a vaccine preventable disease. We are proud that our vaccines can help protect us and our loved ones from a wide range of severe infectious diseases, at every stage of life. We are all driven by a common goal: protect health and empower life.

campus

The Swiftwater, PA, site offers a beautiful campus in the scenic Pocono Mountains and a unique opportunity to encounter the full life cycle of a vaccine from early stages of research and development to manufacturing and post-marketing surveillance. With headquarters in Lyon, France, the Fellow will interact with colleagues at a global level. 

The Fellow will have the opportunity to rotate across the various Sanofi Global Business Units within Pharmacovigilance, including Neurology, Oncology, Rare Blood Disorders, Rare Disease, and Inflammation and Immunology. The Fellow will also gain exposure to other functional areas based on individual interest including Biostatistics, Clinical Development, Medical Affairs, Pharmacoepidemiology, Regulatory Affairs, and Research and Development.

The Fellow is appointed as adjunct faculty at Wilkes University. Academic opportunities include didactic teaching, precepting pharmacy students, global presentations, and projects. The Fellow will be a primary resource to the student chapter of Industry Pharmacists Organization (IPhO). Program Brochure

The pharmaceutical industry is responsible for the monitoring, assessment and communication of safety information throughout a product’s lifecycle. At Sanofi Pasteur, the Global Pharmacovigilance (GPV) Department is responsible for these activities. The purpose of pharmacovigilance is to enhance patient care and safety in relation to the use of pharmaceutical products by ensuring that emerging safety signals are proactively identified and appropriate actions are taken to ensure the benefit/risk profile remains favorable. Pharmacovigilance is a thriving field within the pharmaceutical industry. As regulations continue to expand and evolve, the need for knowledgeable and qualified personnel increases.

Objectives:

During this two-year program, the Fellow will:

  • Understand the mission of a pharmacovigilance department and the role of GPV in clinical development and product lifecycle management
  • Become knowledgeable in current global pharmacovigilance regulations and guidelines, including US and European regulations
  • Develop the ability to think strategically with a global pharmacovigilance and regulatory perspective
  • Enhance the ability to critically evaluate, interpret, synthesize, and present safety data in a clear and concise manner through written and verbal communication
  • Expand medical and scientific knowledge of products within various therapeutic areas
  • Actively participate in:
    • Safety surveillance and signal detection
    • Risk management
    • Preparation of various regulatory documents (e.g. Periodic Safety Reports, Product Label Updates, and Risk Management Plans)

Natalya

Natalya Romanyak, PharmD

Global Pharmacovigilance Fellow
Sanofi Pasteur

Email:  natalya.romanyak@wilkes.edu

Pillay

Joshua Pillay, PharmD, MS

Pharmacovigilence Scientist
Sanofi Pasteur
Fellowship Preceptor

lascombe

Philip Loscombe, PharmD

PV Science Manager
Sanofi Pasteur
Fellowship Director

Judith

Judith L. DeLuca, PharmD

Professor
Chair, Pharmacy Practice
Stark Learning Center
Email: judith.deluca1@wilkes.edu

Moore

Tamala Mallett Moore, MD

Therapeutic Area Head
Sanofi Pasteur
Fellowship Sponsor

Eligibility 

Fellows for the Wilkes University Pharmaceutical Industry Fellowship Program are selected on a nationally competitive basis, with interviews at the American Society of Health System Pharmacists (ASHP) Midyear Meeting.

  • Applicants must have a Doctor of Pharmacy degree from an ACPE accredited college of pharmacy beofre the beginning of the Fellowship.
  • Candidates must have strong written and verbal communication skills and an interest in pursuing a career in the biopharmaceutical industry.   
  • All candidates must have authorization to work in the United States throughout the duration of the two-year fellowship. No visa sponsorship will be provided. 
Application procedure

Attendance and participation at ASHP Midyear/Personnel Placement Service (PPS) is strongly recommended. Please submit an interview request via ASHP/PPS with your curriculum vitae and letter of intent.

After ASHP Midyear Clinical Meeting
All application materials must be submitted electronically to VaccinePVFellowship@sanofi.com no later than December 16, 2019.
 
Formal application for the Fellowship must include:
  • Letter of intent
  • Curriculum vitae
  • Two letters of recommendation (submitted directly by letter writer)
  • One writing sample representative of your medical interpretation skills (e.g. patient case presentation, journal club)
Please address your Letter of Intent & Letters of Recommendation to:
Philip Loscombe, PharmD
Fellowship Director
Sanofi Pasteur
1 Discovery Drive
Swiftwater, PA 18370

©